Arkolith/Insider Trading/PVLA/Form 4

Goin Kathleen

Chief Operating OfficerPALVELLA THERAPEUTICS, INC. (PVLA) · full profile →Form 4 · filed May 22, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$476K
Net Open-Market Flow
-$476K
Transactions
7
5 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 20, 2026Option exercise(M)2K$7.14$15K2K
May 20, 2026Option exercise(M)2K$9.08$20K4K
May 20, 2026Sell(S)3K$110.35$371K939
May 20, 2026Sell(S)891$111.30$99K48
May 20, 2026Sell(S)48$111.89$5K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 20, 2026Option exercise(M)2K—$011K
May 20, 2026Option exercise(M)2K—$011K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-065692) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for PALVELLA THERAPEUTICS, INC.

Build

Ask your agent about PVLA insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001104659-26-065692"
Ask your agent
Use Arkolith to summarize insider buying and selling at PALVELLA THERAPEUTICS, INC.
over the last 90 days and cite the filings.